Page last updated: 2024-08-24

fanasil, pyrimethamine drug combination and Lymphoma, T-Cell

fanasil, pyrimethamine drug combination has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukutomi, Y; Goto, H; Hara, T; Moriwaki, H; Murakami, N; Tajika, M; Tsurumi, H; Yoshimura, K1

Other Studies

1 other study(ies) available for fanasil, pyrimethamine drug combination and Lymphoma, T-Cell

ArticleYear
[Non-Hodgkin's lymphoma with Toxoplasma encephalitis].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Combinations; Encephalitis; Humans; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Pyrimethamine; Remission Induction; Sulfadoxine; Toxoplasmosis, Cerebral; Vincristine

1999